Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

122.96 +1.95 (+1.61%)
Streaming Delayed Price Updated: 2:48 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,059,488
Open 122.10
Bid (Size) 122.94 (4)
Ask (Size) 122.98 (2)
Prev. Close 121.01
Today's Range 121.85 - 123.82
52wk Range 96.06 - 121.24
Shares Outstanding N/A
Dividend Yield 3.25%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FDA Flags Weight Loss Risk In ADHD Meds For Kids — J&J, Novartis Escape New Warning
The updated label applies to extended-release stimulants prescribed off-label to children under six, following data showing higher drug exposure and side effect rates in that age group. 
Via Stocktwits
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
FDA lifts REMS for approved CAR-T therapies, easing hospital restrictions and signaling broader future access in oncology and autoimmune treatment. 
Via Benzinga

Performance

YTD
+26.6%
+26.6%
1 Month
+5.4%
+5.4%
3 Month
+10.3%
+10.3%
6 Month
+26.3%
+26.3%
1 Year
+15.4%
+15.4%

More News

Read More
Could This Be the Best High-Dividend ETF to Buy Right Now?
Via The Motley Fool
Topics ETFs Economy
Incyte CEO Shake-Up Sparks M&A Buzz As RBC Analyst Highlights Meury’s Track Record: Retail Is All In
Via Stocktwits
Topics Intellectual Property
Is Novartis Gaining or Losing Market Support?
Via Benzinga
5 Biotech Stocks with Highly Anticipated Pending Results
Via Stocktwits
Topics Intellectual Property
Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopes
Via Investor's Business Daily
Biogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis' Zolgensma
Via Benzinga
Can Biogen Outdo Its Own Spinal Muscular Atrophy Drug?
Via Investor's Business Daily
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations
Via Stocktwits
Topics Cannabis
Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside
Via Benzinga
NOVARTIS AG-SPONSORED ADR (NYSE:NVS) – A Solid Value Pick in Pharmaceuticals
Via Chartmill
Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Company
Via Benzinga
Novartis' Fabhalta Delivers Hemoglobin Gains, Reduces Fatigue In Patients With Rare Blood Disorder
Via Benzinga
PU Prime Broadens Portfolio with New Global Indices
Via GlobePRwire
Topics Derivatives Economy
2 Dividend Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Topics Intellectual Property
Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position
Via Stocktwits
Topics ETFs
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019
Via Benzinga
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
Via FinancialNewsMedia
Topics Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
From FN Media Group LLC
Via GlobeNewswire
The Smartest Vanguard ETF to Buy With $500 Right Now
Via The Motley Fool
Topics ETFs
Prediction: This "Magnificent Seven" Stock Will Be the Most Valuable Company in the World in 10 Years
Via The Motley Fool
Topics Artificial Intelligence
Lazard Transforms Mutual Fund Into IEQ ETF Amid Rising Demand For International Stocks
Via Benzinga
Topics ETFs
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
Via Benzinga

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 122.96
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 07/01/25 02:48 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.